Consumption of thylakoid-rich spinach extract reduces hunger, increases satiety and reduces cravings for palatable food in overweight women

Appetite

Volumn 91, Issue , 2015, Pages 209-219

  Stenblom, Eva Lena ^a   Egecioglu, Emil ^a   Landin Olsson, Mona ^a   Erlanson Albertsson, Charlotte ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Emotional eating; Liking; Meal supplement; Reward; VAS; Wanting

Indexed keywords

PLACEBO; PLANT EXTRACT; SPINACH EXTRACT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CALORIC INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG INDUCED HEADACHE; FAST FOOD; FEEDING BEHAVIOR; FEMALE; FOOD CRAVING; FOOD INTAKE; HUMAN; HUNGER; INTERVENTION STUDY; MEAL; NAUSEA; OBESITY; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SALTINESS; SATIETY; SPINACH; SWEETNESS; THYLAKOID; VISUAL ANALOG SCALE; CHEMISTRY; DIET THERAPY; DRUG EFFECTS; EATING; EMOTION; FOOD PREFERENCE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYTOTHERAPY; PSYCHOLOGY; TASTE; WITHDRAWAL SYNDROME;

ADULT; AGED; CRAVING; DOUBLE-BLIND METHOD; EATING; EMOTIONS; FEMALE; FOOD PREFERENCES; HUMANS; HUNGER; MIDDLE AGED; OBESITY; OVERWEIGHT; PHYTOTHERAPY; PLANT EXTRACTS; SATIATION; SNACKS; SPINACIA OLERACEA; TASTE; THYLAKOIDS;

EID: 84928743770     PISSN: 01956663     EISSN: 10958304     Source Type: Journal    
DOI: 10.1016/j.appet.2015.04.051     Document Type: Article

References (55)

1. Albertsson P.-Å., Köhnke R., Emek S.C., Mei J., Rehfeld J.F., Åkerlund H.E., et al. Chloroplast membranes retard fat digestion and induce satiety. Effect of biological membranes on pancreatic lipase/co-lipase. The Biochemical Journal 2007, 401:727-733.
2. Baggio L.L., Drucker D.J. Biology of incretins. GLP-1 and GIP. Gastroenterology 2007, 132:2131-2157.
3. Berger K., Winzell M.S., Mei J., Erlanson-Albertsson C. Enterostatin and its target mechanisms during regulation of fat intake. Physiology and Behavior 2004, 83:623-630.
4. Berridge K.C. 'Liking' and 'wanting' food rewards. Brain substrates and roles in eating disorders. Physiology and Behavior 2009, 97:537-550.
5. Berthoud H.-R. Homeostatic and non-homeostatic pathways involved in the control of food intake and energy balance. Obesity (Silver Spring, Md.) 2006, 14(Suppl. 5):197S-200S.
6. Berthoud H.-R. Metabolic and hedonic drives in the neural control of appetite. Who is the boss?. Current Opinion in Neurobiology 2011, 21:888-896.
7. Blundell J., de Graaf C., Hulshof T., Jebb S., Livingstone B., Lluch A., et al. Appetite control. Methodological aspects of the evaluation of foods. Obesity Reviews: An Official Journal of the International Association for the Study of Obesity 2010, 11:251-270.
8. Blundell J.E., Cooling J. Routes to obesity. Phenotypes, food choices and activity. The British Journal of Nutrition 2000, 83(Suppl. 1):S33-S38.
9. Blundell J.E., Gillett A. Control of food intake in the obese. Obesity Research 2001, 9(Suppl. 4):263S-270S.
10. Blundell J.E., Macdiarmid J.I. Fat as a risk factor for overconsumption. Satiation, satiety, and patterns of eating. Journal of the American Dietetic Association 1997, 97(Suppl. 7):S63-S69.
11. Cappelleri J.C., Bushmakin A.G., Gerber R.A. Psychometric analysis of the Three-Factor Eating Questionnaire-R21. Results from a large diverse sample of obese and non-obese participants. International Journal of Obesity 2009, 33(6):611-620.
12. Cummings D.E., Frayo R.S., Marmonier C., Aubert R., Chapelot D. Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues. American Journal of Physiology. Endocrinology and Metabolism 2004, 287:E297-E304.
13. Dickson S., Shirazi R., Hansson C., Bergquist F., Nissbrandt H. The glucagon-like peptide 1 (GLP-1) analogue, Exendin-4, decreases the rewarding value of food. A new role for mesolimbic GLP-1 receptors. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2012, 32(14):4812-4820.
14. Drapeau V., King N., Hetherington M., Doucet E., Blundell J., Tremblay A. Appetite sensations and satiety quotient. Predictors of energy intake and weight loss. Appetite 2007, 48:159-166.
15. Drewnowski A. Taste preferences and food intake. Annual Review of Nutrition 1997, 17:237-253.
16. Drewnowski A., Mennella J.A., Johnson S.L., Bellisle F. Sweetness and food preference. The Journal of Nutrition 2012, 142:1142S-1148S.
17. Egecioglu E., Jerlhag E., Salomé N., Skibicka K.P., Haage D., Bohlooly-Y M., et al. Ghrelin increases intake of rewarding food in rodents. Addiction Biology 2010, 15:304-311.
18. Emek S.C., Szilagyi A., Akerlund H.E., Albertsson P.A., Kohnke R., Holm A., et al. A large scale method for preparation of plant thylakoids for use in body weight regulation. Preparative Biochemistry and Biotechnology 2010, 40:13-27.
19. Epel E., Lapidus R., McEwen B., Brownell K. Stress may add bite to appetite in women. A laboratory study of stress-induced cortisol and eating behavior. Psychoneuroendocrinology 2001, 26:37-49.
20. Erlanson-Albertsson C. How palatable food disrupts appetite regulation. Basic & Clinical Pharmacology & Toxicology 2005, 97:61-73.
21. Ettinger L., Duizer L., Caldwell T. Body fat, sweetness sensitivity, and preference. Determining the relationship. Canadian Journal of Dietetic Practice and Research: A Publication of Dietitians of Canada = Revue canadienne de la pratique et de la recherche en diététique: une publication des Diététistes du Canada 2012, 73:45-48.
22. Fantino M., Hosotte J., Apfelbaum M. An opioid antagonist, naltrexone, reduces preference for sucrose in humans. The American Journal of Physiology 1986, 251:R91-R96.
23. Finkelstein E.A., Khavjou O.A., Thompson H., Trogdon J.G., Pan L., Sherry B., et al. Obesity and severe obesity forecasts through 2030. American Journal of Preventive Medicine 2012, 42:563-570.
24. Finlayson G., King N., Blundell J.E. Liking vs. wanting food. Importance for human appetite control and weight regulation. Neuroscience and Biobehavioral Reviews 2007, 31:987-1002.
25. Flint A., Raben A., Blundell J.E., Astrup A. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 2000, 24:38-48.
26. Flint A., Raben A., Ersbøll A.K., Holst J.J., Astrup A. The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity. International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 2001, 25:781-792.
27. Garber A.K., Lustig R.H. Is fast food addictive?. Current Drug Abuse Reviews 2011, 4:146-162.
28. Gregersen N.T., Flint A., Bitz C., Blundell J.E., Raben A., Astrup A. Reproducibility and power of ad libitum energy intake assessed by repeated single meals. The American Journal of Clinical Nutrition 2008, 87:1277-1281.
29. Karlsson J., Persson L.O., Sjöström L., Sullivan M. Psychometric properties and factor structure of the Three-Factor Eating Questionnaire (TFEQ) in obese men and women. Results from the Swedish Obese Subjects (SOS) study. International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 2000, 24:1715-1725.
30. Keskitalo K., Tuorila H., Spector T.D., Cherkas L.F., Knaapila A., Kaprio J., et al. The Three-Factor Eating Questionnaire, body mass index, and responses to sweet and salty fatty foods. A twin study of genetic and environmental associations. The American Journal of Clinical Nutrition 2008, 88:263-271.
31. Koenders P.G., van Strien T. Emotional eating, rather than lifestyle behavior, drives weight gain in a prospective study in 1562 employees. Journal of Occupational and Environmental Medicine/American College of Occupational and Environmental Medicine 2011, 53:1287-1293.
32. Köhnke R., Lindbo A., Larsson T., Lindqvist A., Rayner M., Emek S.C., et al. Thylakoids promote release of the satiety hormone cholecystokinin while reducing insulin in healthy humans. Scandinavian Journal of Gastroenterology 2009, 44:712-719.
33. Köhnke R., Lindqvist A., Göransson N., Emek S.C., Albertsson P.-Å., Rehfeld J.F., et al. Thylakoids suppress appetite by increasing cholecystokinin resulting in lower food intake and body weight in high-fat fed mice. Phytotherapy Research: PTR 2009, 23:1778-1783.
34. Likert R. A technique for the measurement of attitudes. Archives of Psychology 1932, 22:55.
35. Mela D.J. Eating for pleasure or just wanting to eat? Reconsidering sensory hedonic responses as a driver of obesity. Appetite 2006, 47:10-17.
36. Mesas A.E., Muñoz Pareja M., López García E., Rodríguez Artalejo F. Selected eating behaviours and excess body weight. A systematic review. Obesity Reviews: an official journal of the International Association for the Study of Obesity 2012, 13:106-135.
37. Montelius C., Erlandsson D., Vitija E., Stenblom E.-L., Egecioglu E., Erlanson-Albertsson C. Body weight loss, reduced urge for palatable food and increased release of GLP-1 through daily supplementation with green-plant membranes for three months in overweight women. Appetite 2014, 81:295-304.
38. Montelius C., Osman N., Weström B., Ahrné S., Molin G., Albertsson P.-Å., et al. Feeding spinach thylakoids to rats modulates the gut microbiota, decreases food intake and affects the insulin response. Journal of Nutritional Science 2013, 2:e20.
39. Montelius C., Szwiec K., Kardas M., Lozinska L., Erlanson-Albertsson C., Pierzynowski S., et al. Dietary thylakoids suppress blood glucose and modulate appetite-regulating hormones in pigs exposed to oral glucose tolerance test. Clinical Nutrition (Edinburgh, Scotland) 2013, 33(6):1122-1126. 10.1016/j.clnu.2013.12.009.
40. Montmayeur J.-P., le Coutre J., Drewnowski A., Almiron-Roig E. Human perceptions and preferences for fat-rich foods 2010, CRC Press, Boca Raton, FL.
41. Näslund E., Hellström P.M. Appetite signaling. From gut peptides and enteric nerves to brain. Physiology and Behavior 2007, 92:256-262.
42. Ookuma K., Barton C., York D.A., Bray G.A. Effect of enterostatin and kappa-opioids on macronutrient selection and consumption. Peptides 1997, 18:785-791.
43. Pappas T.N. Physiological satiety implications of gastrointestinal antiobesity surgery. The American Journal of Clinical Nutrition 1992, 55:571S-572S.
44. Raspopow K., Abizaid A., Matheson K., Anisman H. Psychosocial stressor effects on cortisol and ghrelin in emotional and non-emotional eaters. Influence of anger and shame. Hormones and Behavior 2010, 58:677-684.
45. Raun K., von Voss P., Gotfredsen C., Golozoubova V., Rolin B., Knudsen L. Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-IV inhibitor, vildagliptin, does not. Diabetes 2007, 56:8-15.
46. Skibicka K.P. The central GLP-1. Implications for food and drug reward. Frontiers in Neuroscience 2013, 7:181.
47. Skibicka K.P., Hansson C., Egecioglu E., Dickson S.L. Role of ghrelin in food reward. Impact of ghrelin on sucrose self-administration and mesolimbic dopamine and acetylcholine receptor gene expression. Addiction Biology 2012, 17:95-107.
48. Stenblom E.-L., Montelius C., Erlandsson E., Skarping L., Fransson M., Egecioglu E., et al. Decreased urge for palatable food after a two-month dietary intervention with green-plant membranes in overweight women. Obesity and Weight Loss Therapy 2014, in press.
49. Stenblom E.-L., Montelius C., Östbring K., Håkansson M., Nilsson S., Rehfeld J.F., et al. Supplementation by thylakoids to a high carbohydrate meal decreases feelings of hunger, elevates CCK levels and prevents postprandial hypoglycaemia in overweight women. Appetite 2013, 68:118-123.
50. Stubbs R.J., Hughes D.A., Johnstone A.M., Rowley E., Reid C., Elia M., et al. The use of visual analogue scales to assess motivation to eat in human subjects. A review of their reliability and validity with an evaluation of new hand-held computerized systems for temporal tracking of appetite ratings. The British Journal of Nutrition 2000, 84:405-415.
51. Takenaka Y., Shimano T., Yamada Y., Yoshida M., Ohinata K., Yoshikawa M. Enterostatin (APGPR) suppresses the analgesic activity of morphine by a CCK-dependent mechanism. Peptides 2008, 29:559-563.
52. WHO Factsheet N°311: obesity and overweight Last accessed 14.12.11. http://www.who.int/mediacentre/factsheets/fs311/en/.
53. Wishart J.M., Horowitz M., Morris H.A., Jones K.L., Nauck M.A. Relation between gastric emptying of glucose and plasma concentrations of glucagon-like peptide-1. Peptides 1998, 19:1049-1053.
54. Yeomans M.R., Blundell J.E., Leshem M. Palatability. Response to nutritional need or need-free stimulation of appetite?. The British Journal of Nutrition 2004, 92(Suppl. 1):S3-S14.
55. Yoshida R., Ohkuri T., Jyotaki M., Yasuo T., Horio N., Yasumatsu K., et al. Endocannabinoids selectively enhance sweet taste. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:935-939.